Alejandro Galindo - 31 Jan 2022 Form 4/A - Amendment Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Issuer symbol
MNKD
Transactions as of
31 Jan 2022
Net transactions value
+$5,719
Form type
4/A - Amendment
Filing time
24 Aug 2022, 21:00:16 UTC
Date Of Original Report
02 Feb 2022
Previous filing
27 Aug 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock, $0.01 Par Value Award $5,719 +1,804 +0.34% $3.17 539,790 31 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective January 31, 2022.